Lutathera (lutetium Lu 177 dotatate) - Novartis
Subacute disseminated intravascular coagulation following Lu-177 dotatate therapy in a patient with rectal neuroendocrine tumor: A case report (EANM 2026) - Sep 29, 2026 - Abstract #EP-1345; "Subacute DIC represents a rare complication of PRRT treatment. Awareness of delayed onset, high hepatic tumor burden and steroid responsiveness is crucial. Mandatory week 4-6 surveillance and early corticosteroid therapy can prevent fatal outcomes and ensure safe continuation of Lu-177 Dotatate treatment." 
Case report • Clinical • Gastrointestinal Neuroendocrine Tumor • Hematological Disorders • Hematological Malignancies • Hepatocellular Cancer • Hypotension • Infectious Disease • Liver Cancer • Myelodysplastic Syndrome • Neuroendocrine Tumor • Oncology • Solid Tumor • Thrombocytopenia • SSTR
https://www.sciencedirect.com/science/article/pii/S3051291326002855?via%3Dihub
 
P. Lee; H. Cheng; W. Lin; B. Hung; Y. Huang
 
Sep 29, 2026
 
Prev Next